ProtoKinetix, Inc. (PKTX) intrinsic value & 10-year financials

ProtoKinetix, Inc. (PKTX) has no Graham intrinsic value right now because the formula needs positive earnings.

Graham intrinsic value
—
Share price (Oct 17, 2026)
$0.00
Market cap
$71.7K
Revenue (FY2024)
—
ROIC (10-yr avg)
-1296.6%
Free cash flow (FY2024)
-$286.6K

PKTX 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2024 — -$364.2K $0.00 -$286.6K — -93.6%
FY2023 — -$415.5K -$0.01 -$447.1K — -96.9%
FY2022 — -$1.9M -$0.01 -$936.7K — -492.6%
FY2021 — -$2.3M — -$980.9K — -599.4%
FY2020 — -$7.6M — -$951.5K — -1552.8%
FY2019 — -$4.2M — -$873.4K — -1041.2%
FY2018 — -$1.2M — -$491.2K — -392.7%
FY2017 — -$1.5M — -$660.5K — -347.8%
FY2016 — -$1.5M — -$853.7K — -4579.6%
FY2015 — -$1.3M — — — -3769.1%

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

ProtoKinetix, Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.

ProtoKinetix, Inc. has historically struggled to out-earn its cost of capital, averaging just -31.8% ROIC.

ProtoKinetix, Inc. has not shown aggressive share repurchases (>10% retirement) or a major balance-sheet leverage increase (>50% net debt growth) over the 10-year window.

Benjamin Graham lens

ProtoKinetix, Inc. is evaluated under Benjamin Graham's defensive framework using SEC EDGAR fundamentals using an 8.5 + 2g earnings multiple and a 5.1% AAA bond-yield baseline.

PKTX stock: frequently asked questions

What is the intrinsic value of ProtoKinetix, Inc. (PKTX) stock?

Graham's formula only works with positive earnings. ProtoKinetix, Inc. reported diluted EPS of $0.00 in fiscal 2024, so no Graham value is shown. The 10-year table shows revenue and cash-flow trends instead.

Does ProtoKinetix, Inc. generate free cash flow?

ProtoKinetix, Inc. generated -$286.6K of free cash flow (operating cash flow minus capital expenditures) in fiscal 2024. Free cash flow was positive in 0 of the last 9 reported years.

What is PKTX's return on invested capital?

Average ROIC over the last 10 fiscal years was -1296.6%, and average return on equity was -526.6%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this PKTX data come from?

From ProtoKinetix, Inc.'s annual 10-K filings on SEC EDGAR, most recently filed Nov 13, 2025. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar pharmaceutical preparations stocks